Summary
This prediction ended on 23.08.23 with a price of €1.25. With a performance of -5.03%, the BUY prediction by krebskrebs finished with a loss. Dividends of €0.60 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Speqta AB | -5.000% | -5.000% | 1.141% | -98.264% |
| iShares Core DAX® | -2.680% | 4.261% | 2.121% | 57.510% |
| iShares Nasdaq 100 | 0.725% | 5.796% | 34.204% | 92.829% |
| iShares Nikkei 225® | -0.725% | 9.319% | 61.298% | 80.340% |
| iShares S&P 500 | 1.166% | 5.479% | 24.751% | 70.967% |
Comments by krebskrebs for this prediction
In the thread Speqta AB diskutieren
Buy mit Kursziel 4,0
In the thread Trading Speqta AB
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

